Enanta Pharmaceuticals
ENTA
#7946
Rank
HK$2.88 B
Marketcap
HK$99.21
Share price
0.16%
Change (1 day)
74.82%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$1.69 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total liabilities are HK$1.69 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enanta Pharmaceuticals - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-09-30HK$1.68 B-12.75%
2024-09-30HK$1.92 B0.2%
2023-09-30HK$1.92 B352.97%
2022-09-30HK$0.42 B38.51%
2021-09-30HK$0.30 B29.44%
2020-09-30HK$0.23 B10.5%
2019-09-30HK$0.21 B33.21%
2018-09-30HK$0.16 B-17.49%
2017-09-30HK$0.19 B121.62%
2016-09-30HK$87.96 M15.16%
2015-09-30HK$76.37 M45.5%
2014-09-30HK$52.49 M4.05%
2013-09-30HK$50.44 M-20.97%
2012-09-30HK$63.83 M97.81%
2011-09-30HK$32.26 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
HK$938.10 B 55,316.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$623.83 B 36,751.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
HK$1.121 T 66,133.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$55.81 B 3,197.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$648.50 B 38,209.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$520.14 B 30,626.57%๐Ÿ‡บ๐Ÿ‡ธ USA